https://www.selleckchem.com/products/cpi-1205.html
98).The microfluidic CLIA has significant advantages over the conventional ELISA in detection sensitivity, dynamic range, instrument size and turnaround time, and can provide more consistent and reliable results than the lateral flow immunoassays. The compact microfluidic system can perform automated and parallelized CLIA in a short turnaround time, and thus well suited to Point-of-Care detection of disease biomarkers.In this study, we aimed to validate existing plasma assays to measure biomarkers for maternal signalling in milk and sa
Beğen
Yorum Yap
Paylaş
